Peter J King Selected Research

Type 2 Melanocortin Receptor

1/2004	Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene.
12/2002	Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J King Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 09/2009
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 07/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 03/2016
2	Obesity 03/2007 - 10/2002
1	Granuloma 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Adenoma (Adenomas) 10/2019
1	Adrenocortical Carcinoma 10/2019
1	Pheochromocytoma 01/2019
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2018
1	Choriocarcinoma 01/2018
1	Spontaneous Abortion (Miscarriage) 01/2017
1	Fetal Weight 01/2017
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 06/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2014
1	Glioma (Gliomas) 12/2013
1	Pituitary Neoplasms (Pituitary Adenoma) 08/2012
1	Genomic Instability 03/2012
1	Hypertension (High Blood Pressure) 03/2007
1	HIV Infections (HIV Infection) 09/2004
1	Hypersensitivity (Allergy) 01/2004
1	Cushing Syndrome 12/2002

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2012
2	CatecholaminesIBA 07/2019 - 01/2019
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2004 - 12/2002
2	Type 2 Melanocortin ReceptorIBA 01/2004 - 12/2002
2	Corticotropin Receptors (ACTH Receptor)IBA 01/2004 - 12/2002
1	ChemokinesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	futuximabIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Cell Surface ReceptorsIBA 01/2020
1	AldosteroneIBA 10/2019
1	GlucocorticoidsIBA 07/2019
1	MineralocorticoidsIBA 07/2019
1	LuciferasesIBA 01/2018
1	EnzymesIBA 01/2018
1	KisspeptinsIBA 01/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 03/2016
1	Transcription Factors (Transcription Factor)IBA 03/2016
1	Crystallins (Crystallin)IBA 06/2014
1	Amyloid (Amyloid Fibrils)IBA 06/2014
1	polyglutamineIBA 06/2014
1	IntegrinsIBA 12/2013
1	Capsules (Microcapsules)IBA 12/2013
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 08/2012
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 08/2012
1	Minichromosome Maintenance ProteinsIBA 03/2012
1	Protein Kinases (Protein Kinase)IBA 09/2009
1	Angiotensin Receptor AntagonistsIBA 03/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2007
1	SaltsIBA 03/2007
1	HIV IntegraseIBA 09/2004
1	Complementary DNA (cDNA)IBA 09/2004
1	CannabinoidsIBA 10/2002

Therapy/Procedure

2	Therapeutics 01/2020 - 09/2009
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018
1	Protein-Restricted Diet (Diet, Protein Restricted) 03/2007